Clinical trial
Exploration of Microcirculatory Alteration and Endothelial Dysfunction by Adaptive Optics in Multiple Sclerosis
NCT03508089 is registered in ClinicalTrials.gov with Versailles Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploration of Microcirculatory Alteration and Endothelial Dysfunction by Adaptive Optics in Multiple Sclerosis
- Lead sponsor
- Versailles Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 22, 2017
- Completion date
- June 30, 2018
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sclerosis, multiple